SECsense Logo

HCW Biologics Inc. 8-K Filing: Key Updates and Insights for Investors

$HCWB
Form 8-K
Filed on: 2024-12-23
Source
HCW Biologics Inc. 8-K Filing: Key Updates and Insights for Investors

From the provided section of the financial report, here are the key extracted details and insights:

  1. Entity Information:
  • Company Name: HCW Biologics Inc.
  • CIK: 0001828673
  • SEC File Number: 001-40591
  • EIN: 82-5024477
  • Address: 2929 N. Commerce Parkway, Miramar, FL 33025
  • Contact Number: 954-842-2024
  1. Report Type:
  • Filing Type: 8-K
  • Filing Date: December 17, 2024
  1. Stock Information:
  • Common Stock: Par value of $0.0001 per share
  • Ticker Symbol: HCWB
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: December 17, 2024
  • End Date: December 17, 2024
  1. XBRL Information:
  • The filing is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial reporting to enhance transparency and accessibility of financial data.

Insights:

  • The report is a Form 8-K, which is used to announce major events that shareholders should know about. The specific details regarding the content of this filing are not provided, but stakeholders may look for significant developments related to corporate governance, financial results, acquisitions, or other material events.
  • The company is listed on NASDAQ under the ticker HCWB, indicating it is a publicly traded company which may be relevant for investors and analysts monitoring market performance and trends.
  • The filing date being the same as the reporting period suggests that the report may pertain to an event that occurred on that date, possibly indicating immediacy in the information being reported.

Overall, the information suggests that HCW Biologics Inc. is a publicly traded company that is actively communicating with its investors through regulatory filings, which is essential for maintaining transparency and compliance with SEC regulations.